HARNESS
Research type
Research Study
Full title
A randomised controlled trial to compare manual compression and suture-mediated haemostasis after catheter ablation of atrial fibrillation HARNESS: Haemostasis AfteR venous accESS in atrial fibrillation catheter ablation
IRAS ID
345085
Contact name
Dhiraj Gupta
Contact email
Sponsor organisation
Liverpool Heart and Chest Hospital
Duration of Study in the UK
0 years, 11 months, 31 days
Research summary
Atrial fibrillation (AF) is the most common heart rhythm disorder affecting adults in the United Kingdom. In patients with AF who continue to experience symptoms despite medications, catheter ablation is an established interventional treatment. Ablation is performed by inserting a number of plastic tubes in the veins in the groin, in order to access the heart.
Despite continued advances in equipment and techniques, groin complications remain the most common complications after AF ablation. The severity of these can range from minor (e.g. bleeding resolvable with manual pressure) to major (bleeding requiring blood transfusion, prolonged hospitalisation, intervention, or rarely resulting in death).
Following ablation, the plastic tubes in the groin are removed before leaving the procedure room. Once removed, the doctor will stop the bleeding in the groin. There are two commons ways in which the doctor can stop the bleeding: 1) conventional treatment with manual compression – the doctor applies pressure with their hands to the groin area to stop the bleeding; 2) suture treatment (also known as a “stitch”) – the doctor inserts a suture to the groin area and secures this in place with a small plastic device (called a three-way tap). The suture and three-way tap are left in place for a few hours before being removed. Both of these methods are commonly in use. However, there is no high-quality evidence to support whether one way is better than the other.
After stopping the bleeding, patients are generally asked to lay flat for 4 hours to prevent any bleeding. It is not known whether this duration can safely be shortened.
The Haemostasis AfteR veNous accESS in AF catheter ablation (HARNESS) trial is a pragmatic, single-centre, open label, randomised controlled trial which will compare a suture with a three-way tap to manual compression, and examine the impact of bed rest duration on clinical outcomes.
REC name
North West - Preston Research Ethics Committee
REC reference
24/NW/0199
Date of REC Opinion
9 Jul 2024
REC opinion
Favourable Opinion